Abstract
Monoamine oxidase exists in at least four molecular forms in different areas of the human brain. Variations in their enzymatic properties may have important clinical implications, perhaps reflecting their relative ability to degrade different monoamine substrates in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bertler, Å., and Rosengren, E., Acta Physiol. Scand., 47, 350 (1959).
Vogt, M., J. Physiol., 123, 451 (1954).
Amin, A. H., Crawford, T. B. B., and Gaddum, J. H., J. Physiol., 126, 596 (1954).
Bloom, F. E., and Giarman, N. J., Ann. Rev. Pharmacol., 8, 229 (1968).
Kopin, I. J., Pharmacol. Rev., 16, 179 (1964).
Andén, N.-E., Carlsson, A., and Häggendal, J., Ann. Rev. Pharmacol., 9, 119 (1969).
Calne, D. B., Stern, G. M., Laurence, D. R., Sharkey, J., and Armitage, P., Lancet, i, 744 (1969).
Cotzias, G. C., Papavasiliou, P. S., and Gellene, E., New England J. Med., 280, 337 (1969).
Hornykiewicz, O., Pharmacol. Rev., 18, 925 (1966).
Pare, C. M. B., and Sandler, M., J. Neurol. Neurosurg. Psychiat., 22, 247 (1959).
Hendley, E. D., and Snyder, S. H., Nature, 220, 1330 (1968).
Youdim, M. B. H., Collins, G. G. S., and Sandler, M., Nature, 223, 626 (1969).
Hawkins, J., Biochem. J., 50, 577 (1952).
Youdim, M. B. H., and Sourkes, T. L., Canad. J. Biochem., 43, 1305 (1966)
Youdim, M. B. H., Collins, G. G. S., and Sandler, M., in FEBS Symp. 18, Enzymes and Isoenzymes (edit. by Shugar, D.) (Academic Press, New York, in the press).
Tipton, K. F., and Spires, I. P. C., Biochem. Pharmacol., 17, 2137 (1968).
Robinson, D. S., Lovenberg, W., Keiser, H., and Sjoerdsma, A., Biochem. Pharmacol., 17, 109 (1968).
Bogdansky, D. F., and Udenfriend, S., J. Pharmacol. Exp. Ther., 116, 7 (1956).
Gaddum, J. H., and Giarman, N. J., Brit. J. Pharmacol., 11, 88 (1956).
Southgate, J., and Collins, G. G. S., Biochem. Pharmacol., 18, 2285 (1969).
Weiner, N., J. Neurochem., 6, 79 (1960).
Weiber, N., Arch. Biochem. Biophys., 91, 182 (1960).
Zeller, E. A., Barsky, J., Berman, E. R., and Fouts, J. R., J. Pharmacol. Exp. Ther., 106, 427 (1952).
Taylor, J. D., Wykes, A. A., Gladish, Y. C., and Martin, W. B., Nature, 187, 941 (1960).
Udenfriend, S., Witkop, B. G., and Weissbach, H., Biochem. Pharmacol., 1, 160 (1958).
Johnson, J. P., Biochem. Pharmacol., 17, 1285 (1968).
Hall, D. W. R., Logan, B. W., and Parsons, G. H., Biochem. Pharmacol., 18, 1447 (1969).
Kraml, M., Biochem. Pharmacol., 14, 1684 (1965).
Collins, G. G. S., and Youdim, M. B. H., Biochem. J., 114, 80P (1969).
Gorkin, V. Z., Pharmacol. Rev., 18, 115 (1966).
Youdim, M. B. H., and Sandler, M., Biochem. J., 105, 43P (1967).
Squires, R. F., Biochim. Pharmacol., 17, 1401 (1968).
Collins, G. G. S., Youdim, M. B. H., and Sandler, M., FEBS Letters, 1, 215 (1968).
Kim, H. C., and D'Iorio, A., Canad. J. Biochem., 46, 295 (1968).
Ragland, J. B., Biochem. Biophys. Res. Commun., 31, 203 (1968).
Gomes, B., Igaue, I., Kloepfer, H. G., and Yasunobu, K. T., Arch. Biochem. Biophys., 132, 16 (1969).
Youdim, M. B. H., and Collins, G. G. S., Biochem. J. (in the press).
Epstein, C. J., and Schechter, A. N., Ann. NY Acad. Sci., 151, 85 (1968).
Lowry, O. H., Bosebrough, N. J., Farr, A. L., and Randall, R. J., J. Biol. Chem., 193, 265 (1951).
Dixon, M., and Webb, E. C., Enzymes., second ed. (Longmans, London, 1963).
Glenner, G. C., Burtner, H. J., and Brown, G. W., J. Histochem. Cytochem., 5, 591 (1957).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
COLLINS, G., SANDLER, M., WILLIAMS, E. et al. Multiple Forms of Human Brain Mitochondrial Monoamine Oxidase. Nature 225, 817–820 (1970). https://doi.org/10.1038/225817a0
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1038/225817a0
This article is cited by
-
IN SILICO and IN VITRO Estimation of MAO-B Inhibitory Activity of Newly Synthesized Hydrazones Bearing a Pyrrole Heterocyclic System
Pharmaceutical Chemistry Journal (2023)
-
Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR
Advances in Therapy (2021)
-
Selegiline: a molecule with innovative potential
Journal of Neural Transmission (2020)
-
Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases
Journal of Neural Transmission (2018)
-
Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression
Journal of Neural Transmission (2016)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.